Anikó Bohács

Anikó Bohács

Auto-generated profile, based on publicly available information

Anikó Bohács

Department of Pulmonology, Semmelweis University, 1083 Budapest, Hungary

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2010 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
CMC. Máthé
C. Máthé
ABA. Bohács
A. Bohács
LDL. Duffek
L. Duffek
JLJ. Lukácsovits
J. Lukácsovits
ZKZ.I. Komlosi
Z.I. Komlosi
GLG. Losonczy
G. Losonczy
Ageing lung cancer patients may be at increased risk of Cisplatin (Cp) nephrotoxicity, because of comorbidities leading to accelerated ageing of the kidneys. Therefore, the Cp-induced impairement of renal function was compared between no comorbidity (NC) and hypertension plus ischaemic heart disease (CD) patients or others having diabetes mellitus plus ischaemic heart disease (DMIH).In a preliminary study, glomerular filtration rate (GFR) was measured by clearance of technetium 99m-labelled diethylene-thiamine penta-acetate in 38 lung cancer patients with normal serum creatinine concentration ([creat]). Then, the incidence of nephrotoxicity was analysed retrospectively over 1st–4th cycles of Cp treatment among 242 lung cancer patients with initially normal [creat]. GFR was repeatedly estimated using calculated creatinine clearance.Pre-treatment GFR was 57±3 mL·min−1·m−2in those with normal (n = 15) and 42±2 mL·min−1·m−2in those with pathologically increased (n = 23) [creat] any time following their 2nd–4th Cp cycle (p<0.05). The retrospective analysis revealed that Cp-induced nephrotoxicity developed in 7.5% of the NC (n = 80), in 20.9% of the CD (n = 110) and in 30.8% of the DMIH (n = 52) subgroups. Within the overall dropout rate from further Cp chemotherapy, nephrotoxicity was responsible in 14% of NC, 38% in CD and 75% in DMIH patients.A major portion of our ageing lung cancer patients suffered from comorbidities leading to reduced renal resistance to Cp nephrotoxicity.

1 February 2011 in Respiratory Medicine
Verified
Journal Article
Closed access
LTLilla Tamási
Lilla Tamási
Ildikó HorváthIldikó Horváth
Ildikó Horváth
ABAnikó Bohács
Anikó Bohács
VMVeronika Müller
Veronika Müller
GLGyörgy Losonczy
György Losonczy
MSMichael Schatz
Michael Schatz

14 September 2005 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
PDF file
LTL. Tamási
L. Tamási
ABA. Bohács
A. Bohács
ÉPÉ. Pállinger
É. Pállinger
AFA. Falus
A. Falus
JRJ. Rigó
J. Rigó
GLG. Losonczy
G. Losonczy

1 May 2010 in Cell Stress and Chaperones
Verified
Journal Article
Open access
PDF file
LTLilla Tamási
Lilla Tamási
ABAnikó Bohács
Anikó Bohács
VTViola Tamási
Viola Tamási
BSBalázs Stenczer
Balázs Stenczer
ZPZoltán Prohászka
Zoltán Prohászka
AMAttila Molvarec
Attila Molvarec
Asthma is one of the most common diseases complicating pregnancy and represents a risk factor for several maternal and perinatal complications. The natural history of asthma is known to change in pregnancy, but very few data are available in the terms of pathomechanism of this change during gestation. Circulating heat shock protein 70 (Hsp70) levels are decreased in healthy pregnancy, which might reflect physiological immunotolerance. The aim of our study was to determine the serum levels of Hsp70 in asthmatic women during gestation. Forty pregnant women with bronchial asthma and 40 healthy pregnant women matched for maternal and gestational age were involved in this case-control study. Serum Hsp70 levels were measured using the ELISA Kit of R&D Systems. Spirometry and oxygen saturation measurements were performed in asthmatic patients. In asthmatic pregnant women, an increase of serum Hsp70 levels was observed compared to healthy pregnant women (median (25–75 percentile): 0.44 ng/ml (0.36–0.53) versus 0.21 ng/ml (0–0.27), p < 0.001). Fetal birth weight of asthmatic mothers was significantly smaller than of healthy controls, but in the normal range (3,230 g (2,690–3,550) versus 3,550 g (3,450–3,775), p < 0.05). A statistically significant negative correlation between maternal age and serum Hsp70 concentrations (Spearman R = −0.48, p = 0.0018) and a significant positive correlation between gestational age and serum Hsp70 levels (Spearman R = 0.83, p < 0.001) were detected in healthy pregnant women. In conclusion, this study proves an elevation of circulating Hsp70 levels during asthmatic pregnancy compared to healthy pregnant women. However, further studies are warranted to determine the role of circulating Hsp70 in the pathogenesis of maternal and perinatal complications of asthma in pregnancy.

20 September 2011 in International Immunology
Verified
Journal Article
Open access
PDF file
GTGERGELY TOLDI
GERGELY TOLDI
AMAttila Molvarec
Attila Molvarec
BSBalázs Stenczer
Balázs Stenczer
VMVeronika Müller
Veronika Müller
NENoémi Eszes
Noémi Eszes
LTLilla Tamási
Lilla Tamási
Asthma is a common chronic disease that may complicate pregnancy and a risk factor for complications; however, immunological mechanisms of the bilateral interactions between asthma and pregnancy are not fully understood. Healthy gestation is characterized by a sensitive balance of Th1/Th2/Th17/regulatory T (Treg) cells that may be altered in asthmatic pregnancy. The aim of this study was to describe the prevalence of these cell subsets in asthmatic compared with healthy pregnancy. The prevalence of Th1, Th2, Th17 and Treg lymphocytes was identified by cell surface and intracellular marker staining in blood samples of 24 healthy non-pregnant (HNP), 23 healthy pregnant (HP), 15 asthmatic non-pregnant (ANP) and 15 asthmatic pregnant (AP) women using flow cytometry. The Th1/Th2 cell ratio was decreased in both HP and ANP compared with HNP women; however, no further decrease was observed in the AP group. The Th17/Treg ratio was decreased in HP, but not in AP women, compared with HNP data. Healthy pregnancy increased Treg cell prevalence compared with HNP data (4.64% versus 2.98%; P < 0.05), and this pregnancy-induced elevation was absent in AP women (2.52% versus 4.64%; P < 0.05). Th17 cell prevalence was similar in the HP and HNP groups (2.78% versus 3.17%; P > 0.05). Asthma increased Th17 prevalence in non-pregnant patients (3.81% versus 3.17%; P < 0.05), and this asthma-specific increase of Th17 cell prevalence was also observed in AP patients (AP versus HP: 3.44% versus 2.78%; P < 0.05). The abnormal asthma-dependent Th17 elevation together with blunted Treg increase may play a role in the compromised immune tolerance characterizing asthmatic pregnancy.

11 February 2023 in Life
Verified
Journal Article
Open access
PDF file
YAYafet Abidi
Yafet Abidi
ZKZsuzsanna Kovats
Zsuzsanna Kovats
ABAniko Bohacs
Aniko Bohacs
MFMonika Fekete
Monika Fekete
SNSaoussen Naas
Saoussen Naas
JVJanos T. Varga
Janos T. Varga
Background: Both lung transplant recipients and candidates are characterised by reduced training capacity and low average quality of life (QoL). This review investigates the impact of training on exercise ability and QoL in patients before and after lung transplant. Methods: Searches were conducted from the beginning to 7 March 2022 using the terms “exercise,” “rehabilitation,” “lung transplant,” “exercise ability,” “survival,” “quality of life” and “telerehabilitation” in six databases, including Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, CINAHL, Nursing and Allied Health, and Scopus. The inclusion criteria were studies evaluating the effects of an exercise training programme concurrent with lung transplantation as well as patients and candidates (>18 years old) through any lung diseases. The term “lung transplant rehabilitation” was used to refer to all carefully thought-out physical activities with the ultimate or intermediate objective of improving or maintaining physical health. Results: Out of 1422 articles, 10 clinical- and 3 telerehabilitation studies, candidates (n = 420) and recipients (n = 116) were related to the criteria and included in this review. The main outcome significantly improved in all studies. The 6-min walk distance, maximum exercise capacity, peak oxygen uptake, or endurance for constant load rate cycling improved measuring physical activity [aerobic exercises, breathing training, and aerobic and inspiratory muscle training sessions (IMT)]. Overall scores for dyspnoea improved after exercise training. Furthermore, health-related quality of life (HRQOL) also improved after aerobic exercise training, which was performed unsupervised or accompanied by breathing sessions. Aerobic training alone rather than combined with inspiratory muscle- (IMT) or breathing training enhanced exercise capacity. Conclusion: In conclusion, rehabilitation programmes seem to be beneficial to patients both preceding and following lung transplantation. More studies are required to determine the best training settings in terms of time scale, frequency, and work intensity in terms of improving exercise ability, dyspnoea, and HRQOL.